Sinopsis
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
Episodios
-
Episode 115: The GALACTIC-HF Trial
07/04/2021 Duración: 14minJohn Teerlink and C. Michael Gibson discuss omecamtiv mecarbil in chronic HFrEF.
-
Episode 114: The NACMI COVID-19 Registry
24/03/2021 Duración: 28minTimothy Henry and C. Michael Gibson discuss outcomes from the North American registry.
-
Episode 113: The EXPLORER-HCM Trial
17/03/2021 Duración: 10minIacopo Olivotto and C. Michael Gibson discuss mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.
-
Episode 112: FLASH Registry: Acute Hemodynamic Improvement
03/03/2021 Duración: 06minC. Michael Gibson and Catalin Toma discuss acute hemodynamic improvement with percutaneous mechanical thrombectomy in a real-world pulmonary embolism population.
-
Episode 111: The PARALLAX Trial
17/02/2021 Duración: 09minBurkert Pieske and C. Michael Gibson discuss sacubitril/valsartan versus individualized RAAS blockade in HFpEF.
-
Episode 110: The HOME-PE Trial
03/02/2021 Duración: 09minPierre-Marie Roy and C. Michael Gibson discuss hospitalization or outpatient management of PE.
-
Episode 109: The EAST-AFNET 4 Trial
20/01/2021 Duración: 14minPaulus Kirchhof and C. Michael Gibson discuss early rhythm control therapy in patients with atrial fibrillation.
-
Episode 108: The BPLTTC Trial
06/01/2021 Duración: 05minKazem Rahimi and C. Michael Gibson discuss BP-lowering for prevention of cardiovascular events.
-
Episode 107: LoDoCo2 Low-Dose Colchicine in Coronary Disease
16/12/2020 Duración: 07minDr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease.
-
Episode 106: TCT Connect 2020
02/12/2020 Duración: 28minC. Michael Gibson, Ajay Kirtane, Mamas Mamas, and Roxana Mehran talk TCT 2020.
-
Episode 105: POPULAR TAVI
04/11/2020 Duración: 06minC. Michael Gibson and Jorn Brouwer discuss aspirin with or without clopidogrel after transcatheter aortic valve replacement.
-
Episode 104: EMPEROR Reduced
21/10/2020 Duración: 16minC. Michael GIbson and Milton Packer Discuss empagliflozin in heart failure with reduced ejection fraction.
-
Episode 103: New ESC NSTEMI Guidelines
07/10/2020 Duración: 09minC. Michael Gibson and Roxana Mehran discuss new ESC NSTEMI guidelines and more
-
Episode 102: Innovation in Mitral Valve Repair
02/09/2020 Duración: 02minC. Michael Gibson and Steven Goldberg discuss REDUCE-FMR and sham-controlled trials in MV repair.
-
Episode 101: PARTNER 2A: 5-Year Outcomes
19/08/2020 Duración: 02minC. Michael Gibson and Vinod Thourani discuss 5-year outcomes in this randomized trial of TAVR vs SAVR in intermediate-risk patients.
-
Episode 100: COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3
05/08/2020 Duración: 05minSuzanne Baron and C. Michael Gibson discuss important new details from these two structural heart disease trials.
-
Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients
22/07/2020 Duración: 02minC. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.
-
Episode 98: #WomenAs1: The Battle for Gender Equality
15/07/2020 Duración: 06minRoxana Mehran brings C. Michael Gibson up to speed on a campaign to promote talent in medicine by offering professional opportunities to female physicians.
-
Episode 97: TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin
02/07/2020 Duración: 04minUsman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
-
Episode 96: IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI
17/06/2020 Duración: 05minC. Michael Gibson and Myeong-Ki Hong discuss 5-year outcomes in this randomized trial.